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1 Introduction
Glycosylated hemoglobin (HbAj) has been corre-
lated with prior blood glucose levels and has been
in the pregnant and non-pregnant diabetics as a
possible index of both long and short term glucose
control [7]. Factors other than blood glucose
concentration have been reported to alter the
value of HbAj [2]. Hemoglobinopathy is one of
these [1]. This paper reports the results of a
prospective and retrospective evaluation of HbAj
in patients with "normal" and 'Variant" hemo-
globin.
2 Materials and Methods
This study was carried out at Sloane Hospital for
Women of Columbia-Presbyterian Medical Center.
The patients belonged to obstetric clinic popula-
tion, which comprises of 49 percent hispanics,
44 percent blacks, and 7 percent others. Earlier,
the pregnant patients at high risk for diabetes were
screened using plasma sugars (fasting and 2 hours
post 100 gms oral glucose-load) and HbAj as
screening parameters. The mean HbAj in patients
with normal plasma sugars was 6.17 ± 0.6. Seven-
teen patients with HbAj value of 5 or less (2 S.D.
below mean) were identified as study-group-
experimental group. Another group of 17 patients,
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randomly selected and matched according to age,
parity, gestational age and hematocrit with the
first group; and HbAx above 5 gms. percent were
selected as a control group. HbA1 was also meas-
ured in a third group of six patients with known
hemoglobinopathy. The patients in first two
groups were investigated for the presence of hemo-
globinopathy by careful review of their medical
records, sickle cell solubility test or hemoglobin
electrophoresis.
Hemoglobin A t determinations were performed
by cation exchange column chromatography,
using micro-column fast-hemoglobin test system
(ISOLAB, Akron, Ohio). Columns and reagents
were equilibrated at 22 °C—24 °C before perform-
ing and during the test. Blood specimens were
collected in heparinized tubes. Specimens were
tested, when freshly drawn. When this was not
possible, a hemolysate was prepared and stored
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at 4°C. All specimens were analysed within
48 hours. The distribution of the data was evalu-
ated by ordered Chi square analysis and relative
risk assessment.
3 Results
Of seventeen control patients with HbAi greater
than 5 percent, 15 had HbAA or negative sickle
cell solubility test and two had sickle cell trait. Of
seventeen patients with HbA1 less than 5 percent,
14 had sickle cell trait and two had C trait. The
remaining patient had a negative sickle cell solubil-
ity test. The distribution of these cases is shown in
Tab. I.
The mean HbAj in patients with documented
variant Hb was 4.29 ± 0.59 (S.D.) and in 16
patients with HbA, 5.94 ±0.72 (S.D.). The pos-
sibility of this distribution occurring by chance
is less than one in a thousand (X2 = 23.18,
p < 0.001).
The percentage of HbAj in the third group of
patients with known variant Hb is presented in
Tab. II.
The HbAj level was remarkably low in a patient
with Hb Sc disease, markedly elevated in a patient
with S-HPFH (S-high persistence of fetal hemo-
globin), high in thalassemia and Lepore Hb, and
borderline in alpha 2 sickle cell thalassemia.
4 Discussion
Hemoglobin Aj is produced by nonezymatic
glycosylation of hemoglobin A which occurs
slowly throughout the life-span of red blood cells
Tab. I. HbAj in Patients with v'Normal" and "Variant"Hb
Percent HbAj Number of Number of Total
Patients with Patients with
Hb AS or AC Hb AA
Tab. II. HbAj In Patients \y\th Variant Hb (not included
in Tab. I)
Hemoglobinopathy Percent
>5
<5
total No. of
patients
X2 = 23.18
2
16
18
p < 0.001
15
1
'
16
17
17
34
Thalassemia Minor 8.2
Thalassemia Minor 9.1
Hemoglobin SC Disease 1.5
Alpha 2 Sickle Cell - Thalassemia 5.1
S-HPFH (S-high persistence of fetal hemoglobin) 34
A-LeporeHb(ll%) 6.9
[3]. Glycosylation of the N-terminal amino acid of
the beta chain of HbA changes its mobility in
cation exchange chromatography allowing separa-
tion from the parent hemoglobin molecule [3].
Other types of hemoglobin, (such as hemoglobin
S, F or C), also have differing mobilities on cation
exchange column chromatography. Hemoglobin F
happens to elute in the same fraction as HbA l5
whereas hemoglobin S and hemoglobin C elute in
different fractions [1, 7]. It has been shown that
glycosylation occurs in other parts of both the
alpha and beta chains of hemoglobin A, and
presumably of other hemoglobins [5].
Only glycosylation of the N-terminal valine of the
beta chain significantly changes its Chromato-
graphie mobility [5]. Although the alpha, beta and
beta S subunits of a patient with sickle cell trait
may be glycosylated, only hemoglobin with a
glycosylated beta subunit will be measured in the
HbAj fraction. The presence of total glycosylated
hemoglobin in such a patient may, thus, be under-
estimated. This phenomenon has been previously
reported in non-pregnant patient [6]. The signifi-
cant difference in HbAj as measured by column
chromatography between subjects with "normal"
hemoglobin and those with hemoglobin AS and
hemoglobin AC represents a difference in the
presence of glycosylated beta chains rather than
glycosylation per se. Perhaps, for the same reason,
the patient with hemoglobin SC disease had a very
low percentage of HbA! (Tab. II, not included in
Tab. I).
In patients with thalassemia minor, there is a com-
pensatory increase in fetal hemoglobin to make up
for the defect in beta chain synthesis. There may
be no increase in glycosylation. However, since the
Chromatographie mobility of fetal hemoglobin and
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H b A j arc similar, the percentage of HbAj^ in these
patients may be overestimated [7]. This explains
high values of HbAj , in the patients with high
persistence of fetal Hgb and thalassemia minor.
(Tab. II). The patient with alpha-2-thalassemia AS
demonstrated the combined effect of the above
two factors which caused a return of the estima-
tion of HbAj to nearly "normal" values.
FLÜCKIGER and WINTÜRHALTER have described
a colorimetric assay for the determination of
glycosylated hemoglobin. The estimation of
glycosylated hemoglobin obtained with their
method is appropriate to the glucose level and it is
not altered by variant hemoglobins |4]. Our data
suggests that a HbAj value of less than 5 percent,
as measured by cation exchange chromatography
should alert one to the possible presence of hemo-
globinopathy. In patients with apparently normal
carbohydrate tolerance and elevated levels of
HbAx, thalassemia (persistent hemoglobin F)
should be suspected. It should be recognized that
in diabetics with sickle cell trait, the estimation of
may fall in the normal range when measured
by cation exchange column chromatography in
spite of abnormal carbohydrate tolerance. How-
ever, decreasing values of HbAj are representative
of better control of diabetes even in these patients.
5 Conclusion
is a valuable indicator of the integrated
plasma glucose level over the previous 4 to 6
weeks, and therefore, a useful adjunct in the
management of diabetic pregnancy [3]. The
estimation of HbAj by cation exchange column
chromatography enables one to identify patients
with variant hemoglobins. However, obtaining a
single value interferes with the assessment of
diabetes in the patients with hemoglobinopathy.
These technical problems could be overcome if the
colorimetric method was used in the estimation of
glycosylated hemoglobins.
Summary
Glycosylated hemoglobin (HbAj ) is considered to be
representative of prior blood-glucose levels and is being
used in pregnant and nonpregnant diabetic patients as a
possible index of both long and short-term glucose-
control. Factors other than blood-glucose concentration
have been reported to affect its value. Variant hemoglobin
is one of them. HbA^ and blood-glucose levels were
measured in pregnant patients at high risk for diabetes for
screening for abnormal carbohydrate metabolism. HbAj
was measured by cation exchange column chromato-
graphy and glucose was measured by hexokinase reaction.
The mean HbAj in patients with normal blood sugars
Keywords: Glycosylatin, hemoglobin, hemoglobinopathy
was 6.17 ±0.6 percent. A value of H b A j of less than
5 percent as measured by cation exchange column
chromatography was highly predictive (P < 0.001) of
hemoglobinopathies (S or C). The mean HbAj of ran-
domly selected matched patients with "normal" Mb was
5.94 ± 0.72 percent. In patients with thalassemia, HbAj
values as measured by cation exchange column chromato-
graphy were elevated despite normal carbohydrate toler-
ance. While interpreting the results of H b A j in the
management of pregnant diabetics, the above fact should
be kept in mind.
Zusammenfassung
Glykosyliertes Hämoglobin (HbAj[) und Hämoglobino-
pathien in der Schwangerschaft
Es wird angenommen, daß das glykosylierte Hämoglobin
(HbAj) eine repräsentative Aussage über den Blutzucker-
spiegel zuläßt. Man benutzt dieses Maß sowohl bei schwan-
geren Diabetikerinnen wie auch beim üblichen Diabetes
als Index für die länger- wie auch kurzfristige Blutzucker-
kontrolle. Es wurde jedoch berichtet, daß neben dem
Blutzuckerspiegel andere Faktoren, wie z.B. das Variant-
Hämoglobin, den HbAj-Wert beeinflussen können. Wir
bestimmten die HbA| - und Blutzuckerspiegel bei
schwangeren Frauen, die mit einem hohen Diabctes-
risiko behaftet waren, um pathologische Veränderungen
im Kohlcnhydratstoffwechsel aufzudecken. Das HbAj
wurde säulencliromatographisch über einen Kationen-
austauscher bestimmt; die Glucose haben wir mittels der
Hexokinaso-Reaktion gemessen. Bei Patientinnen mit
normalem Blutzuckerspiegel betrug der mittlere H b A j -
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Wert 6,17 ± 0,6 %. Ein säulenchromatographisch bestimm-
ter HbAj-Wert von unter 5 % sagte mit hoher Wahrschein-
lichkeit (p < 0.001) eine Hämoglobinopathie (S oder C)
voraus. Der mittlere HbAj-Wert von zufällig ausgewählten
Patienten mit einem „normalen" Hb betrug 5,94 ± 0,72%.
Bei Patienten mit Thaks^^mie waren die Hb A!-Werte
trotz ungestörter Glucose-Töleranz erhöht. Bei der Inter-
pretation der Hb A i-Werte beim Schwangerschaftsdiabetes
sollten diese Faktoren berücksichtigt werden.
Schlüsselwörter: Glykosylierung, Hämoglobin, Hämogiobinopathien.
Resume
Hemoglobine glycosylee (HbA^) et hemoglobinopathies
pendant la grossesse
L'hemoglobine glydoxylee (HbAj) est consideree comme
representative des taux de glycemies anterieures et est
utilisee chez les patientes diabotiques en cours et en
dehors de la grossesse en tant qu'index du contröle de la
glycemie a court terme aussi bien qu'ä long terme. On a
rapporte que son taux pouvait etre modifie par d'autres
facteurs que la glycemie. Les hemoglobines anormales
representent un de ces facteurs. On a mesure 1'HbAj et
la glycemie chez des patientes enceintes ä haut risque
diabetique en raison de la decouverte d'une anomalie
du motabolisme glucidique. La mesure d'HbAj a ete
effectuee par Chromatographie sur colonne d'echange
cationique et la glycemie par une reaction a Thexokinase.
La valeur moyenne d'HbAj etait de 6,17 ±0,6 pour
cent chez les patientes a glycemie normale. Une valeur
d'HbAj inferieure ä 5 pour cent si eile est determinee par
Chromatographie sur colonne d'echange cationique est
hautement predictive (p < 0,001) d'hemoglobinopathies
(S ou C). La valeur moyenne d'HbAj chez des patientes
avec une hemoglobine «normale» appariees par randomi-
sation est de 5,94±0,72 pour cent. Chez les patientes
thalassemiques les valeurs d'HbAj determinees par
Chromatographie sur colonne sqnt elevees malgre une
tolerance glucidique normale. Lors de l'interpretation
des resultats d'HbAj au cours de la surveillance des
diabetiques enceintes, les faits ci-dessus devraint etre
gares en memoire.
Mots-cles: Glycosylation, hemoglobine, hemoglobinopathie.
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